Journal of Alzheimer s DiseaseGenetic & Genomic MedicinePeer-reviewed journal article
Exploring the genetic heterogeneity of Alzheimer's disease: Evidence for genetic subtypes
Jeremy A. ElmaniD, Nicholas J. SchorkiD, Aaditya V. RanganiD, the Alzheimer’s Disease Neuroimaging Initiative
Abstract
BackgroundAlzheimers disease (AD) exhibits considerable phenotypic heterogeneity, suggesting the potential existence of subtypes. AD is under substantial genetic influence, thus identifying systematic variation in genetic risk may provide insights into disease origins. ObjectiveWe investigated genetic heterogeneity in AD risk through a multi-step analysis. MethodsWe performed principal component analysis (PCA) on AD-associated variants in the UK Biobank (AD cases=2,739, controls=5,478) to assess structured genetic heterogeneity. Subsequently, a biclustering algorithm searched for distinct disease-specific genetic signatures among subsets of cases. Replication tests were conducted using the Alzheimers Disease Neuroimaging Initiative (ADNI) dataset (AD cases=500, controls=470). We categorized a separate set of ADNI individuals with mild cognitive impairment (MCI; n=399) into genetic subtypes and examined cognitive, amyloid, and tau trajectories. ResultsPCA revealed three distinct clusters ( constellations) driven primarily by different correlation patterns in a region of strong LD surrounding the MAPT locus. Constellations contained a mixture of cases and controls, reflecting disease-relevant but not disease-specific structure. We found two disease-specific biclusters among AD cases. Pathway analysis linked bicluster-associated variants to neuron morphogenesis and outgrowth. Disease-relevant and disease-specific structure replicated in ADNI, and bicluster 2 exhibited increased CSF p-tau and cognitive decline over time. ConclusionsThis study unveils a hierarchical structure of AD genetic risk. Disease-relevant constellations may represent haplotype structure that does not increase risk directly but may alter the relative importance of other genetic risk factors. Biclusters may represent distinct AD genetic subtypes. This structure is replicable and relates to differential pathological accumulation and cognitive decline over time.
- organism: human
- assay: GWAS summary statistics
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 9
- FWCI
- 2.56
- Field percentile
- top 11%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Factorization of Alzheimer's disease genetic risk influences allow patient stratification, predicting disease onset, cognitive decline, and cell-type specific responses
Alexandre Pelletier, Tony Tuck, Julia TCW·bioRxiv·Jan 8, 2026
- Dissecting Alzheimer's disease heterogeneity by cross-trait polygenic prediction
William F. Li, Nabil Mohammed, … Yosuke Tanigawa·bioRxiv·May 15, 2026
- Genetic characterization of the ALFA study: Uncovering genetic profiles in the Alzheimer's continuum.
Natàlia Vilor‐Tejedor, Patricia Genius, … for the ALFA study·Alzheimer s & DementiaPeer-reviewed·Dec 13, 2023
- Biobank-scale characterization of Alzheimer's disease and related dementias identifies potential disease-causing variants, risk factors, and genetic modifiers across diverse ancestries
Marzieh Khani, Fulya Akçimen, … Sara Bandrés‐Ciga·medRxiv·Nov 3, 2024
- Alzheimer's subtypesA supervised, unsupervised, multimodal, multilayered embedded recursive (SUMMER) AI study
Sivan Kinreich, Arjun Bingly, Gayathri Pandey·bioRxiv·May 9, 2025
- Manifestations of genetic risk for Alzheimer's Disease in the blood: a cross-sectional multi-omic analysis in healthy adults aged 18-90+
Laura M. Heath, John C. Earls, … Jeffrey Alan Kaye·Scientific ReportsPeer-reviewed·Apr 12, 2022